Mechanisms regulating vimentin-dependent invasion of the brain by Listeria monocytogenes
单核细胞增生李斯特菌依赖波形蛋白入侵大脑的调节机制
基本信息
- 批准号:10415880
- 负责人:
- 金额:$ 38.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-26 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesAstrocytesBacteriaBacterial InfectionsBindingBinding ProteinsBiochemicalBiologicalBiological AssayBloodBlood - brain barrier anatomyBrainCause of DeathCell ExtractsCell surfaceCellsCellular MembraneDiseaseElderlyEncephalitisEndothelial CellsFamily memberFluorescence MicroscopyGastroenteritisGentamicinsGoalsHumanImmunocompromised HostImmunoprecipitationIn VitroIndividualInfectionInfection preventionIntermediate Filament ProteinsIntestinesInvadedKnock-outKnockout MiceLeadLengthLifeLigandsListeria monocytogenesMass Spectrum AnalysisMediatingMembraneMembrane ProteinsMeningitisMultigene FamilyMusNeuraxisNeuronsPathway interactionsPhagocytesPlayPregnant WomenProtein FamilyProteinsRoleSurfaceVimentinblood-brain barrier crossingbrain cellbrain endothelial cellcell typeexperimental studyfoodbornegel electrophoresisin vivoinsightnovelnovel strategiespathogenpathogenic bacteriapathogenic microbepreventprotein protein interactionreceptorrepaired
项目摘要
Project Summary
Listeria monocytogenes (Lm) is an intracellular bacterial pathogen capable of invading numerous host
cell types. Lm infections can lead to severe disease in humans and most often affects immunocompromised
individuals, pregnant women, and the elderly. Of particular concern is the ability of Lm to invade the central
nervous system (CNS), leading to life-threatening meningitis and encephalitis. The identity of factors necessary
to facilitate Lm brain infection has remained unclear. We have recently shown that a Lm surface protein, InlF,
is required for successful colonization of the brain in mice. Moreover, we have determined that InlF binds
vimentin, a cytosolic intermediate filament protein also present on the surface of brain endothelial cells. We
hypothesize that InlF-vimentin interaction is required for Lm passage across the blood-brain barrier (BBB) to
establish an infection in the brain. The focus of this proposal is to elucidate how the InlF-vimentin interaction
mediates invasion of host cells in vitro and Lm infection of the brain in vivo. In Aim I, in vitro infection assays
will be used to determine how InlF interacts with vimentin to mediate invasion of host cells. Confocal
fluorescence microscopy and gentamicin protection assays will be used to directly examine the ability of InlF-
expressing Lm to interact with brain microvascular endothelial cells. Biochemical approaches will be used to
further characterize InlF-vimentin protein binding and identify the regions of vimentin involved in the InlF-
vimentin protein-protein interaction. The mechanisms that regulate cell surface exposure of vimentin are
unknown. We hypothesize that cellular membrane repair pathways facilitate redistribution of cytosolic vimentin
to the surface of host cells. Cell biological studies will be performed to determine the role of membrane repair
pathways for the localization of vimentin to the host cell surface. Additionally, potential vimentin co-receptor
candidates previously identified by mass spectrometry will be examined to determine their role in InlF-mediated
invasion of brain endothelial cells. In Aim II, the contribution of the InlF-vimentin interaction to Lm infection in
vivo will be determined by infection studies in normal and vimentin knockout mice. In vitro infection assays and
fluorescence microscopy will be performed with primary brain cells cultured from normal and knockout mice to
determine if InlF mediates invasion of distinct primary brain cell types (astrocytes and neurons) and determine
the importance of vimentin and potential co-receptors for infection. Gentamicin protection assays with primary
mouse endothelial cells will also be performed to determine if InlF is required for invasion of primary cells that
constitute the BBB. Finally, infection of mice with cell-to-cell spread-defective ΔactA or ΔactA/ΔinlF-derived Lm
strains will determine the in vivo contribution of InlF for colonization of the brain by direct invasion vs. cell-to-
cell spread. The proposed studies will provide insights into the protein-protein interactions and cellular
mechanisms facilitating Lm invasion of the brain and may identify novel targets for preventing infections of the
brain by Lm and other microbial pathogens.
项目摘要
单核细胞增生李斯特菌(Listeriamonocytogenes,Lm)是一种能侵入多种宿主的胞内致病菌
细胞类型。Lm感染可导致严重的疾病在人类和最经常影响免疫功能低下
个人,孕妇和老人。特别值得关注的是Lm入侵中央的能力
神经系统(CNS),导致危及生命的脑膜炎和脑炎。必要因素的确定
导致Lm脑部感染的原因尚不清楚我们最近发现Lm表面蛋白InlF,
是在小鼠大脑中成功定植所必需的。此外,我们已经确定,
波形蛋白,一种也存在于脑内皮细胞表面的胞质中间丝蛋白。我们
假设InIF-波形蛋白相互作用是Lm穿过血脑屏障(BBB)所必需的,
在大脑中建立感染。该提案的重点是阐明InIF-波形蛋白相互作用如何影响细胞的增殖和分化。
介导体外宿主细胞的侵袭和体内脑的Lm感染。在目标I中,体外感染测定
将用于确定InIF如何与波形蛋白相互作用以介导宿主细胞的侵袭。共焦
荧光显微镜和庆大霉素保护试验将用于直接检查InIF的能力。
表达Lm以与脑微血管内皮细胞相互作用。生物化学方法将用于
进一步表征InIF-波形蛋白结合并鉴定参与InIF-波形蛋白结合的波形蛋白区域。
波形蛋白-蛋白相互作用。调节波形蛋白细胞表面暴露的机制是
未知我们假设细胞膜修复途径促进胞浆波形蛋白的重新分布
到宿主细胞的表面。将进行细胞生物学研究以确定膜修复的作用
波形蛋白定位于宿主细胞表面的途径。此外,潜在的波形蛋白共受体
将检查先前通过质谱法鉴定的候选物以确定它们在InIF介导的细胞凋亡中的作用。
脑内皮细胞的侵袭。在目的II中,研究了InIF-波形蛋白相互作用对Lm感染的贡献。
将通过在正常和波形蛋白敲除小鼠中的感染研究来确定体内感染。体外感染测定和
将对从正常和基因敲除小鼠中培养的原代脑细胞进行荧光显微镜检查,
确定InIF是否介导不同的原代脑细胞类型(星形胶质细胞和神经元)的侵袭,并确定
波形蛋白和潜在的共受体对感染的重要性。庆大霉素保护试验,
还将进行小鼠内皮细胞的检测以确定InIF是否是侵袭
构成了BBB。最后,用细胞间扩散缺陷型ΔactA或ΔactA/Δ inlF衍生的Lm感染小鼠,
菌株将通过直接侵袭与细胞间侵袭来确定InIF对脑定殖的体内贡献。
细胞扩散。这些研究将有助于深入了解蛋白质-蛋白质相互作用和细胞生物学行为。
促进Lm侵入大脑的机制,并可能确定预防脑组织感染的新靶点。
脑中的Lm和其他微生物病原体。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cutting Edge: NOX2 NADPH Oxidase Controls Infection by an Intracellular Bacterial Pathogen through Limiting the Type 1 IFN Response.
最前沿:NOX2 NADPH 氧化酶通过限制 1 型 IFN 反应来控制细胞内细菌病原体的感染。
- DOI:10.4049/jimmunol.2000694
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:RojasMárquez,JorgeDavid;Li,Taoyingnan;McCluggage,AdamRR;Tan,JoelMJ;Muise,Aleixo;Higgins,DarrenE;Brumell,JohnH
- 通讯作者:Brumell,JohnH
Listeria exploits IFITM3 to suppress antibacterial activity in phagocytes.
李斯特氏菌利用IFITM3以抑制吞噬细胞中的抗菌活性。
- DOI:10.1038/s41467-021-24982-0
- 发表时间:2021-08-17
- 期刊:
- 影响因子:16.6
- 作者:Tan JMJ;Garner ME;Regeimbal JM;Greene CJ;Márquez JDR;Ammendolia DA;McCluggage ARR;Li T;Wu KJ;Cemma M;Ostrowski PP;Raught B;Diamond MS;Grinstein S;Yates RM;Higgins DE;Brumell JH
- 通讯作者:Brumell JH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Hunter Brumell其他文献
John Hunter Brumell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Hunter Brumell', 18)}}的其他基金
Mechanisms regulating vimentin-dependent invasion of the brain by Listeria monocytogenes
单核细胞增生李斯特菌依赖波形蛋白入侵大脑的调节机制
- 批准号:
10183151 - 财政年份:2019
- 资助金额:
$ 38.53万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 38.53万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 38.53万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 38.53万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 38.53万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 38.53万 - 项目类别: